Cytoskeletal drugs

From Wikipedia, the free encyclopedia

Cytoskeletal drugs are small molecules that interact with actin or tubulin. Some cytoskeltal drugs stabilize a cytoskeletal component, such as taxol which stabilized microtubules. Other prevent polymerization. For example, Cytochalasin D binds to actin monomers and prevents polymerization of actin filaments. Some of these drugs are used therapeutically while others are only available for research.[1]

Drug Name Target cytoskeletal component Effect Clinical applications
Colchicine[2] microtubules prevents polymerization Used to treat gout
Cytochalasins[3] actin prevents polymerization none
Demecolcine[4] microtubules depolymerizes chemotherapy
Latrunculin[5] actin prevent polymerization none
Jasplakinolide[6][7] actin enhances polymerization none
Nocodazole[8] microtubules prevents polymerization none
Paclitaxel (taxol)[9] microtubules stabilizes microtubules and therefore prevents mitosis chemotherarpy
Phalloidin[10] actin stabilizes none
Swinholide[11] actin sequesters actin dimers none
Vinblastine[1] microtubules prevents polymerization none

See also

References

  1. 1.0 1.1 Jordan, M. A.; Leslie, W. (2004). "Microtubules as a Target for Anticancer Drugs". Nature Reviews Cancer 4 (4): 253–265. doi:10.1038/nrc1317. PMID 15057285. 
  2. Vandecandelaere, A ; Martin, S R; Engelborghs, Y (April 1, 1997). "Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules". Biochem J 323 (Pt 1): 189–196. PMC 1218294. PMID 9173881. 
  3. Cooper, J. A. (1987). "Effects of Cytochalasin and Phalloidin on Actin" (pdf). Journal of Cell Biology 105 (4): 1473–1478. doi:10.1083/jcb.105.4.1473. PMC 2114638. PMID 3312229. 
  4. Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature reviews. Cancer 4 (4): 253–65. doi:10.1038/nrc1317. PMID 15057285. 
  5. Yarmola, E.G., Somasundaram, T., Boring, T.A., Spector, I., Bubb, M.R. (2000). "Actin-Latrunculin A Structure and Function". Journal of Biological Chemistry 275 (36): 2812028127. doi:10.1074/jbc.M004253200. PMID 10859320. 
  6. Sasse, F; Kunze, B; Gronewold, TM; Reichenbach, H (Oct 21, 1998). "The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton.". Journal of the National Cancer Institute 90 (20): 1559–63. PMID 9790549. 
  7. Bubb, Michael R.; Spector I., Beyer B.B., Fosen K.M. (2000). "Effects of Jasplakinolide on the Kinetics of Actin Polymerization". J Biol Chem 275 (7): 5163–70. PMID 10671562. 
  8. Vasquez, R.J., et al. (1997). "Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro". Mol. Biol. Cell 8: 973–985. 
  9. Wani M, Taylor H, Wall M, Coggon P, McPhail A (1971). "Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia". J Am Chem Soc 93 (9): 2325–7. doi:10.1021/ja00738a045. PMID 5553076. 
  10. Buchwalow, Igor B., Böcker, Werner (2010). Immunohistochemistry: Basics and Methods. Springer,. p. 92. ISBN 978-3-642-04608-7. 
  11. Bubb, MR; Spector, I; Bershadsky, AD; Korn, ED (1995). "Swinholide a is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments". The Journal of Biological Chemistry 270 (8): 3463–6. PMID 7876075. 
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.